As we can see GTEC had to retrace after it's run, and the time for a reversal as arrived. We can see a bullish divergence forming on the RSI and MACD Histogram. Let's see what the bulls will do this week. A push towards the yellow line (100 ema) would be very nice !)
I am not even getting into cryptocurrency anymore unless Bitcoin goes above $6650. So while I am waiting, I invested some of my portfolio into AKER.
To be honest, I have no idea what they do, but the chart looks very promising. Looking at weekly chart for AKER, we see that there were almost 10 months of bear market, and we see that clear trend...
A chart showing the quarter trend and possible continuation as well as various price and possible spike points. New to this so let me know what you think and time will tell! (prices at the right are for the beginning of july)
We have conflicting signals here, as the RVI is near the sweet spot, the VI (-) is coming up again, VI (+) is stagnating, and the volume hasn't had more than 3 consecutive days of positive momentum for weeks.
Made the breakout confirmation chart last night, forgot to post it. Let me know if you have questions, I can post late if need be. Today (Friday 3/16), we saw the initial breakout for our next run to the upper channel line. Will see big movement next week, $1 by EOW.
When looking at AKER, it is clear that we have a bump due to some "well why the hell not" buyers that just has taken off since mid Feb. This may be one of the safer havens for the Feb, but going in to March, we may see some pullback from the gains just as investors are starting to feel "confident" in their purchases.
When looking at the 1 day, we see increases...
NASDAQ:AKER opening was @ .55. if you placed your buy orders based on the fib lines (0.5106, 0.4854, 0.4602 (didn't touch this one)), you average down and end up green for today, thus have 3 green days in a row...
Volatility breakout after price squeeze. Buy volume no longer there to support the price hike and we're looking at a correction dip.
Short sell, take profit at 61.80% critical support level @0.30.
New and innovative product. Quell's proven technology is 5x more powerful on average than other over-the-counter pain relief devices. It is discreet and completely wearable to enable pain relief when your patients need it.
Increased quarterly earnings growth.
Resistance at at 3.00 range due to the preferred shares being exercisible at...